162 related articles for article (PubMed ID: 35918447)
21. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.
Carrieri G; Bonafè M; De Luca M; Rose G; Varcasia O; Bruni A; Maletta R; Nacmias B; Sorbi S; Corsonello F; Feraco E; Andreev KF; Yashin AI; Franceschi C; De Benedictis G
Hum Genet; 2001 Mar; 108(3):194-8. PubMed ID: 11354629
[TBL] [Abstract][Full Text] [Related]
22. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
[TBL] [Abstract][Full Text] [Related]
23. Novel Alzheimer's disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers.
Park JH; Park I; Youm EM; Lee S; Park JH; Lee J; Lee DY; Byun MS; Lee JH; Yi D; Chung SJ; Park KW; Choi N; Kim SY; Yoon W; An H; Kim KW; Choi SH; Jeong JH; Kim EJ; Kang H; Lee J; Kim Y; Lee EA; Seo SW; Na DL; Kim JW
Transl Psychiatry; 2021 May; 11(1):296. PubMed ID: 34011927
[TBL] [Abstract][Full Text] [Related]
24. New candidate SNPs for genetic association with Alzheimer's disease: a linkage disequilibrium analysis for the FCGRIIB and PILRA genes.
Levi-Monsalve A; Flores SV; Manriquez G; Roco-Videla Á
Medwave; 2024 Feb; 24(1):. PubMed ID: 38408113
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
[TBL] [Abstract][Full Text] [Related]
26. Missing apolipoprotein E ε4 allele associated with nonamnestic Alzheimer's disease in a Tunisian population.
Fray S; Achouri-Rassas A; Belal S; Messaoud T
J Genet; 2022; 101():. PubMed ID: 36226340
[TBL] [Abstract][Full Text] [Related]
27. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.
Haasl RJ; Ahmadi MR; Meethal SV; Gleason CE; Johnson SC; Asthana S; Bowen RL; Atwood CS
BMC Med Genet; 2008 Apr; 9():37. PubMed ID: 18439297
[TBL] [Abstract][Full Text] [Related]
28. Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis.
Abyadeh M; Djafarian K; Heydarinejad F; Alizadeh S; Shab-Bidar S
J Mol Neurosci; 2019 Dec; 69(4):557-562. PubMed ID: 31444704
[TBL] [Abstract][Full Text] [Related]
29. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.
Nacmias B; Tedde A; Latorraca S; Piacentini S; Bracco L; Amaducci L; Guarnieri BM; Petruzzi C; Ortenzi L; Sorbi S
Ann Neurol; 1996 Oct; 40(4):678-80. PubMed ID: 8871590
[TBL] [Abstract][Full Text] [Related]
31. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
[TBL] [Abstract][Full Text] [Related]
32. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
[TBL] [Abstract][Full Text] [Related]
33. ApoE4 makes microglia trem
Heneka MT
Neuron; 2023 Jan; 111(2):142-144. PubMed ID: 36657395
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E genotypes associated with Alzheimer disease and concomitant stroke.
Fekih-Mrissa N; Klai S; Mrad M; Mansour M; Zaouali J; Gritli N; Mrissa R
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):681-5. PubMed ID: 23871727
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum pesticide levels and risk for Alzheimer disease.
Richardson JR; Roy A; Shalat SL; von Stein RT; Hossain MM; Buckley B; Gearing M; Levey AI; German DC
JAMA Neurol; 2014 Mar; 71(3):284-90. PubMed ID: 24473795
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
[TBL] [Abstract][Full Text] [Related]
39. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
Halimi G; Duplan L; Bideau C; Iniesta D; Berthézène P; Oddoze C; Verdier JM; Michel B; Bergé-Lefranc JL
Neuroreport; 2000 Nov; 11(16):3599-601. PubMed ID: 11095526
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E ε4 allele impairs cortical activity in healthy aging and Alzheimer's disease.
Pedroso RV; Fraga FJ; Nascimento CMC; Pott-Junior H; Cominetti MR
Behav Brain Res; 2022 Feb; 420():113700. PubMed ID: 34871705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
